Advanced Search | View Cart | Check Out | 800.284.8433
Bookmark and Share

Hematology Best Practices

The George Washington University Medical Center

The material for Hematology Best Practices has been prepared by medical experts specifically trained in hematology and medical oncology in conjunction with The George Washington University Medical Center to help physicians improve their skills.

  • Panel of hematology-medical oncology experts to help you prepare for your certification/recertification exam
  • Aids practitioners evaluated through the ABMS Maintenance of Certification process
  • Self-study program lets you learn without the expense of travel or time away from your practice. Repeat lectures as needed to reinforce learning of difficult topics

Robert S. Siegel, MD, Course Chair


Preview a sample video from the 2008 program.

watch video


 
CREDITS Earn up to 34 AMA PRA Category 1 Creditsâ„¢.
CE RELEASE December 1, 2009
CE EXPIRE December 1, 2012
 
Item No Media (Can't decide on a format?) Price Purchase
 
Special pricing for clinic-wide orders or for group subscriptions/purchases. Minimum order quantities apply for eligible discounts. For further information and pricing estimates, contact Jack O´ Toole at 1-800-952-0690 x3034. For all other sales inquiries, call 1-800-633-4743.
 

Intended Audience


This activity is designed for the fellow in training, the practitioner of hematology who wishes to review both established standards of care and recent basic and clinical advances in hematology, or the physician planning to take the hematology certifying examination.
 
 

Topics & Speakers


  • Biology of Hematopoiesis
    Jerry L. Spivak, MD

    Professor of Medicine and Oncology,
    Johns Hopkins School of Medicine,
    Baltimore, MD
  • Iron Deficiency and Overload
  • Megaloblastic and Sideroblastic Anemias
  • Hemoglobinopathies
  • Porphyrias
  • Anemia of Chronic Illness
    Victor R. Gordeuk, MD

    Professor of Medicine,
    Center for Sickle Cell Disease,
    Howard University Hospital, Washington, DC
  • RBC Enzymes, Membranes, and Metabolism
  • Hemolytic Anemias
  • Acute Myeloid Leukemia
    Imad Tabbara, MD
    Professor of Medicine, Division of Hematology
    and Oncology, The George Washington University Medical Center, Washington, DC
  • Sickling Disorders
    Gregory J. Kato, MD

    National Heart, Lung, and Blood Institute, Bethesda, MD
  • Mechanisms for Clotting
  • The Hemophilias
    Nigel Key, MD

    Harold R. Roberts Professor, Director, UNC Comprehensive Hemophilia Treatment Center,
    Department of Medicine, Division of Hematology/Oncology, University of North Carolina at Chapel Hill Chapel Hill, NC
  • Von Willebrand's Disease
  • Acquired Disorders of Coagulation
    Margaret Rick, MD

    Adjunct Professor of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD
  • Hypercoagulable States
    Kenneth A. Bauer, MD
    Physician Professor, Beth Israel Deaconess Medical Center, Boston, MA
  • Qualitative Platelet Defects
    A. Koneti Rao, MD

    Professor of Medicine, Thrombosis Research and Pharmacology, Temple University School of
    Medicine, Philadelphia, PA
  • Molecular Diagnostic Methods of
    Common Hematologic Disorders
  • White Cell Disorders
    Nancy Berliner, MD

    Chief, Division of Hematology, Brigham and
    Women's Hospital, Boston, MA
  • Parenteral Antithrombotics and Fibrinolytics
  • Oral Anticoagulants and Anticoagulation Issues
    B. Gail Macik, MD

    Associate Professor of Medicine and Pathology, Health Science Center, University of Virginia Health Science Center, Charlottesville, VA
  • Transfusion Medicine
  • Platelet Alloimmunization
    Thomas Kickler, MD
    Professor of Medicine, Johns Hopkins University, School of Medicine, Baltimore, MD
  • Aplastic Anemia
    Neal S. Young, MD
    Chief, Hematology Branch, NHLBI, Editor, Seminars in Hematology and Editor, Clinical Hematology, National Institutes of Health, Bethesda, MD
  • Consumptive Thrombohemorrhagic Disorders
  • Prothrombotic Complications of Anticoagulation
    Theodore E. Warkentin, MD
    Professor, Department of Pathology and Molecular Medicine, and Department of Medicine McMaster University, Hamilton, Ontario Canada
  • Problems in Hemostasis and Thrombosis
    Drs. Warkentin and Siegel
  • Hematologic Complications of Pregnancy
  • ITP and Drug Related Thrombocytopenias
    Robert S. Siegel, MD
    Professor of Medicine, Director, Division of Hematology and Oncology, The George Washington University Medical Center, Washington, DC
  • Myeloproliferative Neoplasms
    Ayalew Tefferi, MD
    Professor of Medicine, Division of Hematology, Mayo Clinic, Rochester, MN
  • Pathology of Lymphomas
    L. Jeffrey Medeiros, MD
    Professor and Chair, Department of Hematopathology, MD Anderson Cancer Center, Houston, TX
  • Non-Hodgkin's Lymphoma
  • Hodgkin's Disease
    Julie Vose, MD
    Neumann M. and Mildred E. Harris Professor, Chief, Section of Hematology and Oncology, Professor of Medicine, Nebraska Medical School, Omaha, NE
  • Chronic Lymphocytic Leukemia
    Susan O'Brien, MD
    Professor of Medicine, UT MD Anderson Cancer Center, Houston, TX
  • Acute Lymphocytic Leukemia
  • Chronic Myeloid Leukemia watch video
    Hagop Kantarjian, MD
    Professor of Medicine, Department of Leukemia, MD Anderson Cancer Center/Tumor Institute,
    Houston, TX
  • Multiple Myeloma, Plasmacytoma, MGUS
    S. Vincent Rajkumar, MD
    Professor of Medicine, Division of Hematology, Mayo Clinic, Rochester, MN
  • Waldenstom's Macroglobulinemia and Amyloidosis
    Morie A. Gertz, MD
    Professor of Medicine, Division of Hematology, Mayo Clinic, Rochester, MN
  • Myelodysplasia
    Alan F. List, MD
    Professor of Medicine and Chief, Hematologic Malignancies, H. Lee Moffitt Cancer Center, Tampa, FL
  • Morphology Review
    Donald Karcher, MD
    Professor and Acting Chair of Pathology, The George Washington University Medical Center,
    Washington, DC
  • Bone Marrow Transplantation
    Michael Bishop, MD
    Rockville, MD
  • ABO Incompatibility and Other Transfusion Related Issues in Hematopoietic Transplantation
    Charles D. Bolan, MD
    Director, Hematology Fellowship Program, Hematology Branch, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD
  • Pharmacology I, II, and III
    Edward Chu, MD
    Professor and Chief, Section of Medical Oncology, Associate Director, Yale Cancer Center, Yale
    University School of Medicine, New Haven, CT
  • HIV Disease
    Richard Little, MD
    Oncologist, Bethesda, MD
  • Neuro-Oncology
  • Metastatic Disease to the Brain, Spine and Carcinomatous Meningitis
    Howard Fine, MD
    Graduate of University of Pennsylvania, Philadelphia, PA; Graduate of Mount Sinai School of Medicine, New York, NY; Chief, Neuro-Oncology Branch, National Cancer Institute (NCI), National Institutes of Health (NIH); Adjunct Investigator, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH); Adjunct Professor, North Carolina State University; and Adjunct Professor, The George Washington University School of Medicine and Health Sciences

 
 

Learning Objectives


After viewing this activity, participants should be able to:
  • Understand red cell disorders
  • Understand both established information and recent clinical advances in coagulopathies, anticoagulant and thrombolytic therapies
  • Understand blood and marrow morphology and hematopathology
  • Understand both established information and recent clinical advances in immunohematology, bone marrow transplantation, and hematopoietic growth factors

 
 

Accreditation


The George Washington University Medical Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essential Areas, Elements and Policies.

CME Credit

The George Washington University Medical Center designates the Hematology Best Practices for a maximum of 34 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Date of original release: December 1, 2009
Expiration Date: December 1, 2012

The Learning Process

Physician learners are expected to view/listen to all modules, reflect on their content, complete the CME self-assessment and CME evaluation, and return them to the address indicated for scoring. A $30 processing fee must accompany the completed self-assessment and evaluation. Only upon receipt of your self-assessment, evaluation and payment will your CME certificate and correct answers to the self-assessment be mailed to you. The estimated time a learner will need to complete this self-study activity is 34 hours.

Method of Physician Participation: Review recordings of conference sessions and apply knowledge to post-test.

Evaluation Methods: Participants will complete a self-assessment examination to test knowledge gained from viewing the program.


 
 

Notice


The content of this program is developed independently by GW’s Hematology/Medical Oncology Board Review course director, who has no special knowledge or access to American Board of Internal Medicine examinations. The ABIM is not affiliated with, nor does it endorse, any continuing medical education programs.